Skip to main content

Find Clinical Trials

Home
Conditions
Liver Diseases

Clinical trial condition

Liver Diseases

Explore clinical trials studying Liver Diseases. Study availability and eligibility vary by location and protocol.

8,388 public trials 1,305 recruiting studies

Refine in advanced search Browse all conditions

Liver Diseases trial results

Completed

Safety and Efficacy Study of LUM001 (Maralixibat) With a Drug Withdrawal Period in Participants With Alagille Syndrome (ALGS)

NCT02160782

Conditions: Abnormalities, Multiple, Alagille Syndrome, Bile Duct Diseases, +11 more
Locations: Children's Hospital Westmead Westmead, New South Wales, Australia

The Royal Children's Hospital Melbourne Parkville, Victoria, Australia

Cliniques Universitaires Saint-Luc Brussels, Belgium

Hopital Femme Mere Enfant De Lyon Bron, France

View Trial Details

Completed

A Study to Evaluate the Efficacy and Safety of Experimental Drugs ABT- 493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1-6 Infection and Human Immunodeficiency Virus -1 Coinfection (EXPEDITION-2)

NCT02738138

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Chronic Disease, +29 more
Locations: Not specified

View Trial Details

Completed

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Co-administration of ABT-493 and ABT-530 With and Without Ribavirin in Subjects With HCV Genotype 1, 4, 5, and 6 Infection

NCT02243280

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +17 more
Locations: Not specified

View Trial Details

Completed

A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1, 2, 4, 5 or 6 Infection and Compensated Cirrhosis

NCT02642432

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +17 more
Locations: Not specified

View Trial Details

Completed

The Efficacy and Safety of ABT-493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 4, 5, or 6 Infection (ENDURANCE-4)

NCT02636595

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +15 more
Locations: Not specified

View Trial Details

Completed

A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Subjects With Genotype 1 Infection

NCT02604017

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +17 more
Locations: Not specified

View Trial Details

Completed

A Study to Evaluate the Safety and Efficacy of ABT-493/ABT-530 in Adult Post-Liver or Post-Renal Transplant Recipients With Chronic Hepatitis C Virus (MAGELLAN-2)

NCT02692703

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +17 more
Locations: Not specified

View Trial Details

Completed

A Study to Evaluate the Safety and Effect of the Experimental Drugs ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 in Subjects With Chronic Hepatitis C

NCT01674725

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C Infection, +15 more
Locations: Not specified

View Trial Details

Completed

A Study to Evaluate Chronic Hepatitis C Infection in Adults With Genotype 1b Infection

NCT01767116

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C Infection, +15 more
Locations: Not specified

View Trial Details

Completed

A Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir With Sofosbuvir With or Without Ribavirin in Adults With Chronic Hepatitis C Virus Infection

NCT02292719

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C Virus Infection, +15 more
Locations: Not specified

View Trial Details